10/20/2011 10:17:17 AM
CHANDLER, Ariz.--(BUSINESS WIRE)--InNexus Biotechnology Inc. (TSX: IXS.V), a biopharmaceutical company creating and developing innovative solutions for cancer, inflammation and other difficult-to-treat diseases, today announced that it has appointed Angela Giannoccaro as its Chief Financial Officer. Ms. Giannoccaro assumed her role on October 17th, 2011. She will oversee InNexus non-research and development administrative functions in addition to her financial management responsibilities.
comments powered by